技術文章/ article

您的位置:首頁  -  技術文章  -  核苷逆轉錄酶 (nucleoside reverse transcriptase) 抑制劑——拉米夫定

核苷逆轉錄酶 (nucleoside reverse transcriptase) 抑制劑——拉米夫定

更新時間:2024-01-12      瀏覽次數:3765

Lamivudine  


CAS號134678-17-4

英文名Lamivudine  

中文名拉米夫定

Synonyms: 拉米夫定; BCH-189

純度99+%

Formula  C8H11N3O3S          分子量  229.26

Appearance   White to off-white solid

生物活性Lamivudine (BCH-189) is an orally active nucleoside reverse transcriptase inhibitor (NRTI). Lamivudine can inhibit HIV reverse transcriptase 1/2 and also the reverse transcriptase of hepatitis B virus. Lamivudine salicylate can penetrate the CNS.

Lamivudine (BCH-189) 是一種具有口服活性的核苷逆轉錄酶 (nucleoside reverse transcriptase) 抑制劑 (NRTI)Lamivudine 可以抑制 HIV 逆轉錄酶 1 2 以及乙型肝炎病毒 (hepatitis B virus) 的逆轉錄酶。Lamivudine 可以透過血腦屏障。

研究領域

Reverse Transcriptase (逆轉錄酶)

Reverse transcriptases (RTs) are enzyme used to generate complementary DNA (cDNA) from an RNA template, a process termed reverse transcription. Reverse transcriptases (RTs) use an RNA template and a short primer complementary to the 3' end of the RNA to direct the synthesis of the first strand cDNA.

Nucleoside reverse transcriptase inhibitors (NRTIs) block reverse transcriptase (an HIV enzyme). Non-nucleoside reverse transcriptase inhibitors (NNRTIs) bind to and block HIV reverse transcriptase. HIV uses reverse transcriptase to convert its RNA into DNA (reverse transcription). Blocking reverse transcriptase and reverse transcription prevents HIV from replicating.

HIV (人類免疫缺陷病毒)

Human immunodeficiency virus

HIV (Human immunodeficiency virus) is a lentivirus (a subgroup of retrovirus) that causes the acquired immunodeficiency syndrome (AIDS), a condition in humans in which progressive failure of the immune system allows life-threatening opportunistic infections and cancers to thrive. Infection with HIV occurs by the transfer of blood, semen, vaginal fluid, pre-ejaculate, or breast milk. Within these bodily fluids, HIV is present as both free virus particles and virus within infected immune cells. HIV infects vital cells in the human immune system such as helper T cells (specifically CD4+ T cells), macrophages, and dendritic cells. HIV infection leads to low levels of CD4+ T cells through a number of mechanisms, including apoptosis of uninfected bystander cells, direct viral killing of infected cells, and killing of infected CD4+ T cells by CD8 cytotoxic lymphocytes that recognize infected cells. When CD4+ T cell numbers decline below a critical level, cell-mediated immunity is lost, and the body becomes progressively more susceptible to opportunistic infections.

Anti-infection (抗感染)

Anti-infectives are drugs that can either kill an infectious agent or inhibit it from spreading. Anti-infectives include antibiotics and antibacterials, antifungals, antivirals and antiprotozoals.

Antibiotics specifically treat infections caused by bacteria, most commonly used types of antibiotics are: Aminoglycosides, Penicillins, Fluoroquinolones, Cephalosporins, Macrolides, and Tetracyclines. New other approaches such as photodynamic therapy (PDT) and antibacterial peptides have been considered as alternatives to kill bacteria.

The high rates of morbidity and mortality caused by fungal infections are associated with the current limited antifungal arsenal and the high toxicity of the compounds. The most common antifungal targets include fungal RNA synthesis and cell wall and membrane components, though new antifungal targets are being investigated.

Viral infections occur when viruses enter cells in the body and begin reproducing, often causing illness. Viruses are classified as DNA viruses or RNA viruses, RNA viruses include retroviruses, such as HIV, are prone to mutate. The currently available antiviral drugs target 4 main groups of viruses: herpes, hepatitis, HIV and influenza viruses. Drug resistance in the clinical utility of antiviral drugs has raised an urgent need for developing new antiviral drugs.

Antiprotozoal drugs are medicines that treat infections caused by protozoa. Of which, malaria remains a major world health problem following the emergence and spread of Plasmodium falciparum that is resistant to the majority of antimalarial drugs. At present, antimalarial discovery approaches have been studied, such as the discovery of antimalarials from natural sources, chemical modifications of existing antimalarials, the development of hybrid compounds, testing of commercially available drugs that have been approved for human use for other diseases and molecular modelling using virtual screening technology and docking.

HBV (乙型肝炎病毒)

Hepatitis B virus

HBV (Hepatitis B virus), abbreviated HBV, is a species of the genus Orthohepadnavirus, which is likewise a part of the Hepadnaviridae family of viruses. HBV causes the disease hepatitis B. The hepatitis B virus is classified as the type species of the Orthohepadnavirus, which contains three other species: the Ground squirrel hepatitis virus, Woodchuck hepatitis virus, and theWoolly monkey hepatitis B virus. The genus is classified as part of the Hepadnaviridae family. HBV is divided into four major serotypes (adr, adw, ayr, ayw) based on antigenic epitopes present on its envelope proteins, and into eight genotypes (A–H) according to overall nucleotide sequence variation of the genome. The genotypes have a distinct geographical distribution and are used in tracing the evolution and transmission of the virus. Differences between genotypes affect the disease severity, course and likelihood of complications, and response to treatment and possibly vaccination.

參考文獻

[1]. Colledge D, et al. Synergistic inhibition of hepadnaviral replication by lamivudine in combination with penciclovir in vitro. Hepatology. 1997 Jul;26(1):216-25.

[2]. Olaniyan LW, et al. Lamivudine-Induced Liver Injury. Open Access Maced J Med Sci. 2015 Dec 15;3(4):545-50.  

[3]. Mdanda S, et al. Zidovudine and Lamivudine as Potential Agents to Combat HIV-Associated Neurocognitive Disorder. Assay Drug Dev Technol. 2019 Oct;17(7):322-329.


公司簡介  >  在線留言  >  聯系我們  >  

CONTACT

辦公地址:中國(上海)自由貿易試驗區臨港新片區新楊公路1666號3幢315室 EMAIL:2885066715@qq.com
掃碼關注公眾號
版權所有©2025 凱立德生物醫藥技術(上海)有限公司 All Rights Reserved   備案號:滬ICP備15046197號-1   sitemap.xml技術支持:化工儀器網   管理登陸

TEL:021-58180488

掃碼關注公眾號
主站蜘蛛池模板: 中文字幕av无码一区二区三区电影 | 免费人妻无码不卡中文字幕系| 久久亚洲精品成人无码| 99久久国产热无码精品免费| 国产自无码视频在线观看| 亚洲精品无码你懂的| 97久久精品亚洲中文字幕无码| 中文字幕在线无码一区| 青青草无码免费一二三区| 亚洲AV无码一区二区三区在线观看 | 亚洲va中文字幕无码久久不卡 | 中文字幕无码免费久久| 亚洲熟妇av午夜无码不卡| 亚洲精品无码mv在线观看网站| 精品人妻无码专区中文字幕 | 内射人妻无码色AV天堂| 国产∨亚洲V天堂无码久久久| 午夜无码视频一区二区三区| 麻豆精品无码国产在线果冻 | 国产午夜无码精品免费看动漫| 久久中文字幕无码一区二区| 中文无码字慕在线观看| 日韩精品久久无码人妻中文字幕 | 最新无码人妻在线不卡| 亚洲∧v久久久无码精品| 无码av免费网站| 无码人妻丰满熟妇区免费| 久久久久亚洲av成人无码电影| 无码视频一区二区三区| 久久综合一区二区无码| 无码国模国产在线观看免费| 中文字幕av无码不卡免费| 精品无码国产一区二区三区51安| 无码国产精品一区二区免费 | 无码日韩人妻av一区免费| 男人av无码天堂| 无码人妻av一区二区三区蜜臀| 无码专区国产精品视频| 亚洲熟妇少妇任你躁在线观看无码| 国语成本人片免费av无码| 精品久久久无码中字|